William, Samuel
Duncan, Todd
Redmond, T. Michael
Funding for this research was provided by:
the Intramural Research Program of the National Institutes of Health, National Eye Institute
National Institutes of Health
Article History
Received: 17 August 2022
Accepted: 14 December 2022
First Online: 23 December 2022
Competing interests
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Samuel William has a patent on “Methods of treatment using sterculic acid” issued to the National Eye Institute, NIH. The other authors declare no competing interest.